Editorial: Advances in ME/CFS Research and Clinical Care

Frontiers in Pediatrics

article

Kenneth J. Friedman¹  Lucinda Bateman²  Alison Bested³  Zaher Nahle⁴ 

[1] United States;Bateman Horne Center, United States;Integrative Medicine, Nova Southeastern University College of Osteopathic Medicine, United States;Arthritis National Research Foundation, United States

关键词: Myalgic Encephalomyelitis;    Chronic Fatigue Syndrome;    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome;    ME/CFS;    chronic illness;    stigmatized illness;    diagnosis;    treatment;   

DOI  :  10.3389/fped.2019.00370

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Advances in ME/CFS Research and Clinical Care spotlights Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a maligned, stigmatized, under-researched disease, which lacks a definitive, objective clinical test for its diagnosis, and definitive palliative and curative treatments. A few brave physicians attempt to alleviate the suffering of the afflicted. They rely upon the patients’ symptoms to guide them. Physicians can provide symptomatic relief and improve upon patients’ abnormal physiological and metabolic parameters by intervening to cause the latter to approach normal limits. Documented to be more severely disabling than HIV-AIDS, ME/CFS receives disturbingly little funding in the United States and around the world. ME/CFS patients constitute an identifiable, underserved population that is in need of the recognition which would raise them from their current, underserved or non-served patient status into the mainstream of healthcare worldwide. ME/CFS is a common disease worldwide, affecting approximately 1 percent of the world’s population.

【 授权许可】

CC BY